These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 828106)

  • 1. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.
    Seiden LS; Fischman MW; Schuster CR
    Drug Alcohol Depend; 1976 Feb; 1(3):215-9. PubMed ID: 828106
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
    Scheel-Krüger J
    Eur J Pharmacol; 1971; 14(1):47-59. PubMed ID: 4396660
    [No Abstract]   [Full Text] [Related]  

  • 3. Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice.
    Yamanaka Y; Yamamoto T; Egashira T
    Jpn J Pharmacol; 1983 Feb; 33(1):33-40. PubMed ID: 6683768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs.
    Wagner GC; Seiden LS; Schuster CR
    Drug Alcohol Depend; 1979 Sep; 4(5):435-8. PubMed ID: 510182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity changes to dopaminergic agents in fine motor control of rhesus monkeys after repeated methamphetamine administration.
    Ando K; Johanson CE; Seiden LS; Schuster CR
    Pharmacol Biochem Behav; 1985 May; 22(5):737-43. PubMed ID: 4011634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of chronic methamphetamine administration in rhesus monkeys.
    Woolverton WL; Ricaurte GA; Forno LS; Seiden LS
    Brain Res; 1989 May; 486(1):73-8. PubMed ID: 2720435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of morphine tolerance and physical dependence in rats depleted of brain catecholamines by 6-hydroxydopamine.
    Elchisak MA; Rosecrans JA
    Neuropharmacology; 1979 Feb; 18(2):175-82. PubMed ID: 571053
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of reserpine in morphine-tolerant rats: absence of an antagonism of catecholamine depletion.
    Blosser JC; Catravas GN
    J Pharmacol Exp Ther; 1974 Nov; 191(2):284-9. PubMed ID: 4422904
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamine levels and tyrosine hydroxylase activities in rat brain regions after chronic treatment with, and withdrawal of, methamphetamine.
    Bardsley ME; Bachelard HS
    Biochem Pharmacol; 1981 Jun; 30(12):1543-9. PubMed ID: 6115646
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of evidence for the involvement of catecholaminergic mechanisms in the behavioral anti-methamphetamine effect of L-histidine in the mouse.
    Itoh Y; Oishi R; Nishibori M; Saeki K; Furuno K; Fukuda T; Araki Y
    Pharmacol Biochem Behav; 1986 Mar; 24(3):571-4. PubMed ID: 3703891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic methods to study the release of catecholamines from the neostriatum in nonanaesthetized monkeys (Macaca mulatta).
    Bioulac B; Cheramy A; Besson MJ; Rodriquez F; Glowinski J; Gauchy C; Vincent JD
    J Med Primatol; 1979; 8(2):95-104. PubMed ID: 113547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to p-chloroamphetamines effects on Sidman avoidance performance and catecholamine metabolism.
    Steranka LR; Sanders-Bush E; Barrett RJ
    Neuropharmacology; 1977 Nov; 16(11):761-9. PubMed ID: 22829
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain monoamines in the rhesus monkey during long-term neuroleptic administration.
    Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 24():315-23. PubMed ID: 6157310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of single and repeated doses of p-bromo-methamphetamine on the monoamine content and turnover rate in rat brain.
    Zsilla G; Knoll B; Knoll J
    Neuropharmacology; 1981 Sep; 20(9):833-8. PubMed ID: 6170025
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 16. Methamphetamine: toxicity to dopaminergic neurons.
    Seiden LS
    NIDA Res Monogr; 1985; 62():100-16. PubMed ID: 2867472
    [No Abstract]   [Full Text] [Related]  

  • 17. Dyskinesias elicited by methamphetamine: susceptibility of former methadone-consuming monkeys.
    Eibergen RD; Carlson KR
    Science; 1975 Nov; 190(4214):588-90. PubMed ID: 810889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of butacaine hemisulfate on brain and heart catecholamine concentrations of the mouse.
    Dorris RL; Gage TW
    Pharmacol Res Commun; 1980 Feb; 12(2):155-61. PubMed ID: 6446090
    [No Abstract]   [Full Text] [Related]  

  • 19. Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs.
    Nybäck H; Borzecki Z; Sedvall G
    Eur J Pharmacol; 1968 Nov; 4(4):395-403. PubMed ID: 5724916
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence.
    Vaupel DB; Schindler CW; Chefer S; Belcher AM; Ahmet I; Scheidweiler KB; Huestis MA; Stein EA
    Drug Alcohol Depend; 2016 Feb; 159():181-9. PubMed ID: 26775284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.